Back to News
Market Impact: 0.3
Charles River Laboratories Lifts Annual Outlook- Update
Source: Nasdaq
Corporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
Charles River Laboratories raised its 2026 outlook for organic revenue growth and earnings per share. The article provides no revised figures or additional details on the magnitude of the increase.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
CRL0.75
More News
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Voters rebuff data centers in every ballot measure except one during the 2026 midterms
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales
- Softbank’s $5.4 bln takeover of ABB robotics unit blocked by China- FT
- After the midterms, Big Tech’s AI data center problem is only getting bigger
- Snap shares fall over 10% on third-quarter earnings miss